skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Structures of potent anticancer compounds bound to tubulin

Abstract

Abstract Small molecules that bind to tubulin exert powerful effects on cell division and apoptosis (programmed cell death). Cell‐based high‐throughput screening combined with chemo/bioinformatic and biochemical analyses recently revealed a novel compound MI‐181 as a potent mitotic inhibitor with heightened activity towards melanomas. MI‐181 causes tubulin depolymerization, activates the spindle assembly checkpoint arresting cells in mitosis, and induces apoptotic cell death. C2 is an unrelated compound previously shown to have lethal effects on microtubules in tumorigenic cell lines. We report 2.60 Å and 3.75 Å resolution structures of MI‐181 and C2, respectively, bound to a ternary complex of αβ‐tubulin, the tubulin‐binding protein stathmin, and tubulin tyrosine ligase. In the first of these structures, our crystallographic results reveal a unique binding mode for MI‐181 extending unusually deep into the well‐studied colchicine‐binding site on β‐tubulin. In the second structure the C2 compound occupies the colchicine‐binding site on β‐tubulin with two chemical moieties recapitulating contacts made by colchicine, in combination with another system of atomic contacts. These insights reveal the source of the observed effects of MI‐181 and C2 on microtubules, mitosis, and cultured cancer cell lines. The structural details of the interaction between tubulin and the described compounds may guide the developmentmore » of improved derivative compounds as therapeutic candidates or molecular probes to study cancer cell division.« less

Authors:
 [1];  [1];  [2];  [3]
  1. Department of Chemistry and Biochemistry University of California, Los Angeles Los Angeles California 90095
  2. Department of Chemistry and Biochemistry University of California, Los Angeles Los Angeles California 90095, Molecular Biology Institute, University of California Los Angeles Los Angeles California 90095, Department of Energy Institute for Genomics and Proteomics University of California Los Angeles Los Angeles California 90095
  3. Department of Chemistry and Biochemistry University of California, Los Angeles Los Angeles California 90095, Molecular Biology Institute, University of California Los Angeles Los Angeles California 90095, Jonsson Comprehensive Cancer Center University of California Los Angeles Los Angeles California 90095
Publication Date:
Sponsoring Org.:
USDOE
OSTI Identifier:
1226512
Alternate Identifier(s):
OSTI ID: 1295972
Grant/Contract Number:  
DE‐AC02–06CH11357
Resource Type:
Journal Article: Published Article
Journal Name:
Protein Science
Additional Journal Information:
Journal Name: Protein Science Journal Volume: 24 Journal Issue: 7; Journal ID: ISSN 0961-8368
Publisher:
Wiley Blackwell (John Wiley & Sons)
Country of Publication:
United Kingdom
Language:
English

Citation Formats

McNamara, Dan E., Senese, Silvia, Yeates, Todd O., and Torres, Jorge Z. Structures of potent anticancer compounds bound to tubulin. United Kingdom: N. p., 2015. Web. doi:10.1002/pro.2704.
McNamara, Dan E., Senese, Silvia, Yeates, Todd O., & Torres, Jorge Z. Structures of potent anticancer compounds bound to tubulin. United Kingdom. https://doi.org/10.1002/pro.2704
McNamara, Dan E., Senese, Silvia, Yeates, Todd O., and Torres, Jorge Z. 2015. "Structures of potent anticancer compounds bound to tubulin". United Kingdom. https://doi.org/10.1002/pro.2704.
@article{osti_1226512,
title = {Structures of potent anticancer compounds bound to tubulin},
author = {McNamara, Dan E. and Senese, Silvia and Yeates, Todd O. and Torres, Jorge Z.},
abstractNote = {Abstract Small molecules that bind to tubulin exert powerful effects on cell division and apoptosis (programmed cell death). Cell‐based high‐throughput screening combined with chemo/bioinformatic and biochemical analyses recently revealed a novel compound MI‐181 as a potent mitotic inhibitor with heightened activity towards melanomas. MI‐181 causes tubulin depolymerization, activates the spindle assembly checkpoint arresting cells in mitosis, and induces apoptotic cell death. C2 is an unrelated compound previously shown to have lethal effects on microtubules in tumorigenic cell lines. We report 2.60 Å and 3.75 Å resolution structures of MI‐181 and C2, respectively, bound to a ternary complex of αβ‐tubulin, the tubulin‐binding protein stathmin, and tubulin tyrosine ligase. In the first of these structures, our crystallographic results reveal a unique binding mode for MI‐181 extending unusually deep into the well‐studied colchicine‐binding site on β‐tubulin. In the second structure the C2 compound occupies the colchicine‐binding site on β‐tubulin with two chemical moieties recapitulating contacts made by colchicine, in combination with another system of atomic contacts. These insights reveal the source of the observed effects of MI‐181 and C2 on microtubules, mitosis, and cultured cancer cell lines. The structural details of the interaction between tubulin and the described compounds may guide the development of improved derivative compounds as therapeutic candidates or molecular probes to study cancer cell division.},
doi = {10.1002/pro.2704},
url = {https://www.osti.gov/biblio/1226512}, journal = {Protein Science},
issn = {0961-8368},
number = 7,
volume = 24,
place = {United Kingdom},
year = {Wed May 27 00:00:00 EDT 2015},
month = {Wed May 27 00:00:00 EDT 2015}
}

Journal Article:
Free Publicly Available Full Text
Publisher's Version of Record at https://doi.org/10.1002/pro.2704

Citation Metrics:
Cited by: 18 works
Citation information provided by
Web of Science

Save / Share:

Works referenced in this record:

Discovery of Cytotoxic Dolastatin 10 Analogues with N-Terminal Modifications
journal, December 2014


Identification of a Small Molecule That Induces Mitotic Arrest Using a Simplified High-Content Screening Assay and Data Analysis Method
journal, February 2006


Structural basis for the regulation of tubulin by vinblastine
journal, May 2005


Linking Crystallographic Model and Data Quality
journal, May 2012


Chemical dissection of the cell cycle: probes for cell biology and anti-cancer drug development
journal, October 2014


Microtubules and resistance to tubulin-binding agents
journal, February 2010


Microtubules as a target for anticancer drugs
journal, April 2004


Mitosis-targeted anti-cancer therapies: where they stand
journal, October 2012


The 4 Å X-Ray Structure of a Tubulin:Stathmin-like Domain Complex
journal, September 2000


Structural plasticity of tubulin assembly probed by vinca-domain ligands
journal, July 2012


Highly enantioselective synthesis and cellular evaluation of spirooxindoles inspired by natural products
journal, July 2010


Ligand identification using electron-density map correlations
journal, December 2006


PHENIX : building new software for automated crystallographic structure determination
journal, October 2002


electronic Ligand Builder and Optimization Workbench ( eLBOW ): a tool for ligand coordinate and restraint generation
journal, September 2009


The Novel Microtubule-Destabilizing Drug BAL27862 Binds to the Colchicine Site of Tubulin with Distinct Effects on Microtubule Organization
journal, April 2014


A new tubulin-binding site and pharmacophore for microtubule-destabilizing anticancer drugs
journal, August 2014


Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model
journal, June 1985


Tools for integrated sequence-structure analysis with UCSF Chimera
journal, July 2006


Microtubule-binding agents: a dynamic field of cancer therapeutics
journal, October 2010


Stathmin Family Proteins Display Specific Molecular and Tubulin Binding Properties
journal, February 2001


XDS
journal, January 2010


Geometric characteristics of hydrogen bonds involving sulfur atoms in proteins
journal, July 2009


UCSF Chimera?A visualization system for exploratory research and analysis
journal, January 2004


Diversity-oriented synthesis as a tool for identifying new modulators of mitosis
journal, January 2014


The Binding of Vinca Domain Agents to Tubulin: Structural and Biochemical Studies
book, January 2010


Phase I/IIa trial of the novel microtubule inhibitor BAL101553 in advanced solid tumors: Phase I completed.
journal, May 2014


Automated ligand fitting by core-fragment fitting and extension into density
journal, July 2006


RM1: A reparameterization of AM1 for H, C, N, O, P, S, F, Cl, Br, and I
journal, July 2006


Weak Nonbonded S···X (X = O, N, and S) Interactions in Proteins. Statistical and Theoretical Studies.
journal, July 2002


15 Å Resolution Model of the Monomeric Kinesin Motor, KIF1A
journal, January 2000


The contribution of αβ-tubulin curvature to microtubule dynamics
journal, November 2014


Molecular Mechanism of Action of Microtubule-Stabilizing Anticancer Agents
journal, January 2013


Variations in the colchicine-binding domain provide insight into the structural switch of tubulin
journal, August 2009


MolProbity : all-atom structure validation for macromolecular crystallography
journal, December 2009


Coot model-building tools for molecular graphics
journal, November 2004


Identification of Simple Compounds with Microtubule-Binding Activity That Inhibit Cancer Cell Growth with High Potency
journal, November 2011


Structure of a kinesin–tubulin complex and implications for kinesin motility
journal, July 2013


A designed ankyrin repeat protein selected to bind to tubulin caps the microtubule plus end
journal, July 2012


Hydrogen-Bond Acceptor and Donor Properties of Divalent Sulfur ( Y -S- Z and R -S-H)
journal, August 1997


Studies on Lysogenesis i.
journal, January 1951


High Content Screening of Diverse Compound Libraries Identifies Potent Modulators of Tubulin Dynamics
journal, February 2014


Structural Basis of Microtubule Stabilization by Laulimalide and Peloruside A
journal, January 2014


Refined structure of αβ-tubulin at 3.5 Å resolution 1 1Edited by I. A. Wilson
journal, November 2001


Structural insight into the inhibition of tubulin by vinca domain peptide ligands
journal, September 2008


Discovery of Novel 2-Aryl-4-benzoyl-imidazole (ABI-III) Analogues Targeting Tubulin Polymerization As Antiproliferative Agents
journal, August 2012


Optimal description of a protein structure in terms of multiple groups undergoing TLS motion
journal, March 2006


Structural Model for Tubulin Recognition and Deformation by Kinesin-13 Microtubule Depolymerases
journal, March 2013


Structural basis of tubulin tyrosination by tubulin tyrosine ligase
journal, January 2013


Structure of the αβ tubulin dimer by electron crystallography
journal, January 1998


Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain
journal, March 2004


Phaser crystallographic software
journal, July 2007